Adam M. Mendizabal

发表

Neurodevelopmental outcomes of umbilical cord blood transplantation in metachromatic leukodystrophy.

M. Poe, J. Provenzale, J. Kurtzberg, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Transendocardial mesenchymal stem cells and mononuclear bone marrow cells for ischemic cardiomyopathy: the TAC-HFT randomized trial.

Darcy L. DiFede, Peter A. Altman, R. Hendel, 2014, JAMA.

Allogeneic Human Mesenchymal Stem Cells in Patients With Idiopathic Pulmonary Fibrosis via Intravenous Delivery (AETHER): A Phase I Safety Clinical Trial

G. Rosen, J. Minkiewicz, M. Glassberg, 2017, Chest.

Multicenter biologic assignment trial comparing reduced-intensity allogeneic hematopoietic cell transplant to hypomethylating therapy or best supportive care in patients aged 50 to 75 with intermediate-2 and high-risk myelodysplastic syndrome: Blood and Marrow Transplant Clinical Trials Network #110

E. Leifer, F. Appelbaum, M. Horowitz, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Umbilical Cord Blood Transplantation in Children with Acute Leukemia: Impact of Conditioning on Transplant Outcomes Blood Marrow

J. Wagner, J. Kurtzberg, D. Wall, 2017 .

Allogeneic hematopoietic cell transplant for HIV patients with hematologic malignancies: the BMT CTN-0903/AMC-080 trial.

J. Mellors, D. Porter, M. Horowitz, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

International patterns of childhood chronic myeloid leukemia: Comparisons between the United States and resource‐restricted nations

P. Levine, G. Reaman, K. Sadak, 2014, Pediatric blood & cancer.

Effect of aging on human mesenchymal stem cell therapy in ischemic cardiomyopathy patients.

E. Ghersin, J. Hare, J. Fishman, 2014, Journal of the American College of Cardiology.

Cardiosphere-derived cells for heart regeneration – Authors’ reply

E. Marbán, R. Makkar, R. Smith, 2012, The Lancet.

Rationale and Design of the Percutaneous Stem Cell Injection Delivery Effects on Neomyogenesis in Dilated Cardiomyopathy (The POSEIDON-DCM Study)

A. Heldman, J. Hare, S. Gomes, 2014, Journal of Cardiovascular Translational Research.

Autologous Mesenchymal Stem Cells

P. Pattany, A. Lardo, A. Heldman, 2014 .

Rationale and design of the Transendocardial Injection of Autologous Human Cells (bone marrow or mesenchymal) in Chronic Ischemic Left Ventricular Dysfunction and Heart Failure Secondary to Myocardial Infarction (TAC-HFT) trial: A randomized, double-blind, placebo-controlled study of safety and effi

Peter A. Altman, A. Heldman, D. Rouy, 2011, American heart journal.

Randomized Comparison of Allogeneic Versus Autologous Mesenchymal Stem Cells for Nonischemic Dilated Cardiomyopathy: POSEIDON-DCM Trial.

R. Hendel, P. Pattany, Mauricio G. Cohen, 2017, Journal of the American College of Cardiology.

Allogeneic Mesenchymal Stem Cells Ameliorate Aging Frailty: A Phase II Randomized, Double-Blind, Placebo-Controlled Clinical Trial

A. Heldman, A. Oliva, A. Landin, 2017, The journals of gerontology. Series A, Biological sciences and medical sciences.

Autologous Mesenchymal Stem Cells Produce Concordant Improvements in Regional Function, Tissue Perfusion and Fibrotic Burden when Administered to Patients Undergoing Coronary Artery Bypass Grafting – The PROMETHEUS Trial

P. Pattany, A. Lardo, A. Heldman, 2014 .

Myeloablative versus Reduced-Intensity Conditioning for Hematopoietic Cell Transplantation in Acute Myelogenous Leukemia and Myelodysplastic Syndromes-Long-Term Follow-Up of the BMT CTN 0901 Clinical Trial.

E. Leifer, N. Geller, D. Porter, 2021, Transplantation and cellular therapy.

105: Augmentation of Standard Umbilical Cord Blood Transplantation with ALDHbr Cells: Results of a Phase I Study in Pediatric Patients

J. Kurtzberg, A. Balber, D. Hickerson, 2008 .

Myeloablative Versus Reduced-Intensity Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndromes.

E. Leifer, N. Geller, H. Deeg, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Immune Recovery Following Autologous Hematopoietic Stem Cell Transplantation in HIV-Related Lymphoma Patients on the BMT CTN 0803/AMC 071 Trial

C. Hofmeister, A. Krishnan, W. Wachsman, 2021, Frontiers in Immunology.

Phase II trial of parathyroid hormone after double umbilical cord blood transplantation.

E. Shpall, J. Wingard, K. Ballen, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Phase II Trial of Parathyroid Hormone following Double Umbilical Cord Blood Transplantation

E. Shpall, J. Wingard, K. Ballen, 2012 .

A scheme for defining cause of death and its application in the T cell depletion trial.

J. Wagner, E. Copelan, D. Hurd, 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Prednisone (PDN)/Sirolimus (SRL) Compared to PDN/SRL/Calcineurin Inhibitor (CNI) as Treatment for Chronic Graft-Versus-Host-Disease (cGVHD): A Randomized Phase II Study from the Blood and Marrow Transplant Clinical Trials Network

M. Horowitz, J. Bolaños-Meade, Stephanie J. Lee, 2016 .

Comparison of allogeneic vs autologous bone marrow–derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial.

Joshua M Hare, Phillip Ruiz, Peter A. Altman, 2012, JAMA.

Results of a Phase III Randomized, Multi-Center Study of Allogeneic Stem Cell Transplantation after High Versus Reduced Intensity Conditioning in Patients with Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia (AML): Blood and Marrow Transplant Clinical Trials Network (BMT CTN) 0901

E. Leifer, N. Geller, H. Deeg, 2015 .

Myeloablative transplantation using either cord blood or bone marrow leads to immune recovery, high long-term donor chimerism and excellent survival in chronic granulomatous disease.

J. Kurtzberg, H. Malech, V. Prasad, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Most Closely HLA-Matched Allogeneic Virus Specific Cytotoxic T-Lymphocytes (CTL) to Treat Persistent Reactivation or Infection With Adenovirus, CMV and EBV After Hemopoietic Stem Cell Transplantation (HSCT)

S. Pai, H. Heslop, C. Rooney, 2010 .

A phase II/III randomized, multicenter trial of prednisone/sirolimus versus prednisone/ sirolimus/calcineurin inhibitor for the treatment of chronic graft-versus-host disease: BMT CTN 0801

M. Horowitz, J. Bolaños-Meade, Stephanie J. Lee, 2018, Haematologica.

Juan Wu, M. Eapen, E. Fuchs, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Blood and Marrow Transplant Clinical Trials Network Report on the Development of Novel Endpoints and Selection of Promising Approaches for Graft-versus-Host Disease Prevention Trials.

M. Perales, F. Appelbaum, D. Porter, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.